- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
Associate Director - Risk & Assurance, LACAN | Panama | Panama | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Jan 08, 2025 |
Senior Legal Counsel, Trade Sanctions | London (The Westworks) | United Kingdom | Legal | Innovative Medicines | Legal & Intellectual Property & Compl. | Jan 08, 2025 |
Juriste - CDD H/F | Paris Headquarter (Novartis Pharma S.A.S.) | France | Legal | Innovative Medicines | Legal & Intellectual Property & Compl. | Jan 07, 2025 |
Global Security Investigations Associate Director | Basel (City) | Switzerland | Legal | Corporate | Legal & Intellectual Property & Compl. | Dec 19, 2024 |
CHARGE BONNES PRATIQUES | Rueil-Malmaison | France | International | Innovative Medicines | Legal & Intellectual Property & Compl. | Dec 17, 2024 |
Manager - Risk & Assurance | Moscow (City) | Russian Fed. | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Dec 13, 2024 |
Associate Director, Ethics Risk & Compliance, Operations | East Hanover | USA | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Dec 12, 2024 |
Country Head of ERC, Japan | Head Office (Japan) (Pharmaceuticals) | Japan | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Dec 06, 2024 |
Senior IP Counsel | East Hanover | USA | Legal | Innovative Medicines | Legal & Intellectual Property & Compl. | Dec 03, 2024 |
Head Quality Operations, Legal | East Hanover | USA | Legal | CTS | Legal & Intellectual Property & Compl. | Dec 03, 2024 |
Associate Director, Labor Rights EMEA | Prague | Czech Republic | Ethics Risk & Compliance | Corporate | Legal & Intellectual Property & Compl. | Nov 22, 2024 |
Head Legal APMA | Mapletree Business City (MBC) | Singapore | Legal | Innovative Medicines | Legal & Intellectual Property & Compl. | Nov 14, 2024 |
Functional Lead, Compliance Analytics and Reporting | Telangana | India | Operations | CTS | Legal & Intellectual Property & Compl. | Sep 18, 2024 |
Ethics, Risk & Compliance Manager | Selangor | Malaysia | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Aug 22, 2024 |
Patent Paralegal | Cambridge (USA) | USA | Legal | Pharma Research | Legal & Intellectual Property & Compl. | Jul 19, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى